In the latest trading session,, 0.42 million Mesoblast Ltd ADR (NASDAQ:MESO) shares changed hands as the company’s beta touched 3.50. With the company’s most recent per share price at $11.90 changing hands around $1.95 or 19.60% at last look, the market valuation stands at $1.36B. MESO’s last price was a premium, traded about 7.14% off its 52-week high of $11.05. The share price had its 52-week low at $1.61, which suggests the last value was 86.47% up since then. When we look at Mesoblast Ltd ADR’s average trading volume, we note the 10-day average is 0.15 million shares, with the 3-month average coming to 154.03K.
Analysts gave the Mesoblast Ltd ADR (MESO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 2 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended MESO as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Mesoblast Ltd ADR’s EPS for the current quarter is expected to be -0.25.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mesoblast Ltd ADR (NASDAQ:MESO) trade information
Instantly MESO is in green as seen in intraday trades today. With action 36.31%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 440.91%, with the 5-day performance at 36.31% in the green. However, in the 30-day time frame, Mesoblast Ltd ADR (NASDAQ:MESO) is 23.70% up. Looking at the short shares, we see there were 1.39 million shares sold at short interest cover period of 6.69 days.
The consensus price target for the stock as assigned by Wall Street analysts is 11.5, meaning bulls need a downside of -3.48% from its recent market value. According to analyst projections, MESO’s forecast low is 11 with 12 as the target high. To hit the forecast high, the stock’s price needs a -0.84% plunge from its current level, while the stock would need to tank 7.56% for it to hit the projected low.
Mesoblast Ltd ADR (MESO) estimates and forecasts
Data shows that the Mesoblast Ltd ADR share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 65.28% over the past 6 months, a 16.85% in annual growth rate that is considerably lower than the industry average of 17.10%. Year-over-year growth is forecast to reach 125.20% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 3.47M. 1 analysts are of the opinion that Mesoblast Ltd ADR’s revenue for the current quarter will be 4.19M.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.34%. The 2024 estimates are for Mesoblast Ltd ADR earnings to increase by 35.84%, but the outlook for the next 5-year period is at 48.80% per year.
MESO Dividends
Mesoblast Ltd ADR is expected to release its next quarterly earnings report on 2025-Feb-26.
